MedTrace Logo

Retinal Neurodegeneration In Type 2 Diabetes Mellitus Detected by Optical Coherence Tomography

NCT04808804 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-03-23

No results posted yet for this study

Summary

Evaluation of retinal neurodegeneration in patients with type 2 diabetes mellitus (DM2) without diabetic retinopathy or with mild non proliferative diabetic retinopathy

Conditions

Interventions

DIAGNOSTIC_TEST

Optical Coherence Tomography (OCT)

a noninvasive imaging technology used to obtain high resolution cross-sectional images of the retina

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-30
Primary Completion
2022-03-31
Completion
2022-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04808804 on ClinicalTrials.gov